The design of our study is fixed and based on the current test (FIT; FOB-Gold; Sentinel Diagnostics, Milan, Italy), cut-off (47 μg Hb/g feces) and age range (individuals aged 55–75) used in the Dutch CRC screening program. This evidence concerns the gene GSTM1 and colorectal carcinoma.